[N1-metal sulfa drugs and zincpolyanemine and its derivatives in prevention of burn wound sepsis].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000517:prevention & control*; D002056:Burns / Q000150:complications*; D005260:Female; D008297:Male; D009942:Organometallic Compounds; D011725:Pyridines / Q000627:therapeutic use*; D051381:Rats; D012837:Silver Sulfadiazine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*; D014946:Wound Infection / Q000517:prevention & control*
D000900:Anti-Bacterial Agents; D009942:Organometallic Compounds; D011725:Pyridines; D013449:Sulfonamides; C010423:pyrithione zinc; D012837:Silver Sulfadiazine